June 28, 2022 by Chain Drug Review
Boots, No7 Beauty Company, Rosalind Brewer, WBA
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) announced on Tuesday its decision to keep its Boots and No7 Beauty Company businesses under its existing ownership. This marks the conclusion of the review that began in January in line with the company’s strategic priorities. WBA has been encouraged by productive discussions held with a range of
May 11, 2022 by Chain Drug Review
AmerisourceBergen, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill.– Walgreens Boots Alliance, Inc. (WBA) has sold 6.0 million shares of AmerisourceBergen Corp. common stock pursuant to Rule 144 at a price of $150 per share. After the sale, Walgreens Boots Alliance’s ownership of AmerisourceBergen’s common stock has decreased from approximately 28.1% to approximately 25.2%. The sale has no impact to the long-term
March 31, 2022 by Chain Drug Review
Roz Brewer, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Increased demand for COVID-19 tests and vaccines helped lift Walgreens Boots Alliance Inc.’s second quarter results above Wall Street’s projections, as the omicron variant peaked during the period. WBA reported adjusted earnings of $1.59 per share in the three months ended Feb. 28. Revenue rose 3% to $33.76 billion. Analysts’ consensus estimates
March 14, 2022 by Chain Drug Review
Elena Kraus, WBA
Leading Headlines, Retail News
SAN ANTONIO — Elena Kraus is departing Walgreens to take on the role of executive vice president and chief legal officer at the Whataburger restaurant chain. Kraus is a seasoned executive with more than 30 years of in-house legal experience at Walgreen Boots Alliance. For the past six years, she served as senior vice president
March 14, 2022 by Jeffrey Woldt
Roz Brewer, Walgreens, WBA
Featured Articles, Leading Headlines, March 14, 2022, Retail News
DEERFIELD, Ill. — Roz Brewer has brought an analytical bent to Walgreens Boots Alliance during her first year as chief executive officer. Trained as a chemist at Spelman College, she brings a methodical, fact-based approach to solving problems related to the businesses of health care, pharmacy and retailing. “You always have to reach back and
February 23, 2022 by Chain Drug Review
Boots, WBA
Leading Headlines, Retail News
LONDON — According to published reports, Walgreens Boots Alliance (WBA) is said to have set a Thursday (February 24th) deadline for bids for its U.K.-based Boots chain that could value the company at as much as 8B pounds ($10.9B). Walgreens gained almost 1% in premarket trading. Asda owner TDR Capital and a consortium of CVC
February 22, 2022 by Chain Drug Review
Social and Governance 2021 (ESG) Report, WBA, WBA announced the release of its fiscal 2021 Environmental
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance, Inc. (WBA) announced the release of its fiscal 2021 Environmental, Social and Governance 2021 (ESG) Report, which outlines the company’s commitment to its four corporate responsibility pillars – Healthy Communities, Healthy Planet, Healthy and Inclusive Workplace and Sustainable Marketplace – all at the heart of its purpose to create
February 3, 2022 by Chain Drug Review
Steven Shulman, WBA
Business, Leading Headlines, Retail News
DEERFIELD, Ill. – Walgreens Boots Alliance, Inc. (WBA) announced the appointment of Steven Shulman to the company’s board of directors. He joins the board as a director, effective Jan. 27, 2022, and becomes the board’s eleventh member. Shulman brings a wealth of healthcare management experience, as well as an extensive leadership background in emerging healthcare
January 31, 2022 by Chain Drug Review
Boots UK, WBA
Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) is being reported to have started the sales process for its Boots chain in the U.K. after confirming it was considering selling the unit earlier this month. according to Bloomberg News. The company sent out preliminary information to possible bidders ahead of first round bids expected in the
January 12, 2022 by Chain Drug Review
Boots, WBA
Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) has begun a strategic review of its U.K.-based Boots business, according to a Reuters report, which cites remarks made by WBA chief executive officer Rosalind Brewer Tuesday at the J.P Morgan Healthcare Conference. “This review is very much in line with our renewed priorities and strategic direction,”
January 6, 2022 by Chain Drug Review
Brewer, first quarter, Walgreens, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance far surpassed analysts’ expectations for first quarter profits, as adjusted earnings per share jumped 53.2% to $1.68. Wall Street’s consensus forecast for adjusted EPS was $1.33. With customers flocking to stores for COVID vaccines and tests, sales for the period ended November 30 climbed 7.8% from the year-ago quarter
January 4, 2022 by Chain Drug Review
40th Annual J.P. Morgan Healthcare Conference, WBA
Business, Leading Headlines, Retail News
DEERFIELD, Ill. – Walgreens Boots Alliance, Inc. (WBA) announced Tuesday that chief executive officer, Roz Brewer, and executive vice president and global chief financial officer, James Kehoe, will present at the 40th Annual J.P. Morgan Healthcare Conference, Tuesday, Jan. 11 at 2:15 p.m. Eastern time. The conference is a virtual event. The appearance will be
January 3, 2022 by Chain Drug Review
Bain Capital, Walgreens Boots Alliance (WBA), WBA
Leading Headlines
DEERFIELD, Ill. — According to various published reports in the U.K., Walgreens Boots Alliance may sell its Boots pharmacies to private equity firms. The Sunday Times in London said Walgreens “received an acquisition approach from Bain Capital more than two months ago” and “is positioning itself as a leader in an upcoming auction for boots
December 6, 2021 by Chain Drug Review
Boots, WBA
Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance is thinking of selling its Boots chain in the U.K. in order to focus more on its North American business, according to published reports. The company has reportedly enlisted Goldman Sachs to advise it on its options, which include selling the British chain, keeping it, or listing it as